To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Thoma Bravo shuts down Imprivata process amid coronavirus downturn, LPs assess risk of ‘nightmare scenario’ with capital call credit lines, NY Common forms co-invest partnership with Neuberger Berman
Thoma Bravo calls off its potential $2 billion-plus sale of Imprivata amid the coronavirus pandemic and New York State Common Retirement Fund commits to a $2 billion co-investment fund with Neuberger Berman.
